{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:10:13Z","timestamp":1788765013904,"version":"build-2803163510"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12015-026-11197-3","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:23:15Z","timestamp":1785349395000},"page":"3417-3438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Harnessing Endogenous Plasticity Rather than Reprogramming of Mature Cells Will Advance Regenerative Medicine, Cancer Treatment and Rejuvenation"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5384-3998","authenticated-orcid":false,"given":"Deepa","family":"Bhartiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nripen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"7","key":"11197_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jcyt.2025.01.015","volume":"27","author":"J Takahashi","year":"2025","unstructured":"Takahashi, J. (2025). iPSC-based cell replacement therapy: from basic research to clinical application. Cytotherapy, 27(7), 835\u2013842. https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.015","journal-title":"Cytotherapy"},{"key":"11197_CR2","doi-asserted-by":"publisher","unstructured":"Kirkeby, A., Main, H., & Carpenter, M. (2025). Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update. Cell Stem Cell, 32(1), 10\u201337. https:\/\/doi.org\/10.1016\/j.stem.2024.12.005","DOI":"10.1016\/j.stem.2024.12.005"},{"issue":"11","key":"11197_CR3","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s44222-024-00220-2","volume":"2","author":"M Generali","year":"2024","unstructured":"Generali, M., Fujita, Y., Kehl, D., Hirosawa, M., Emmert, M. Y., Takahashi, J., Hoerstrup, S. P., & Saito, H. (2024). Purification technologies for induced pluripotent stem cell therapies. Nature Reviews Bioengineering, 2(11), 930\u2013943. https:\/\/doi.org\/10.1038\/s44222-024-00220-2","journal-title":"Nature Reviews Bioengineering"},{"issue":"13","key":"11197_CR4","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1016\/j.cell.2024.05.040","volume":"187","author":"S Yamanaka","year":"2024","unstructured":"Yamanaka, S., & Shinya Yamanaka (2024). Cell. ;187(13):3229\u20133230. doi:10.1016\/j. cell.2024.05.040.","journal-title":"Cell"},{"issue":"4","key":"11197_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.33963\/v.phj.104577","volume":"83","author":"E Krogulec","year":"2025","unstructured":"Krogulec, E., Dobosz, A. M., Stefanowski, N., Kendziorek, M. E., Janikiewicz, J., & Dobrzy\u0144, A. (2025). From potential to practice: Overcoming the immaturity of iPSC-derived cardiomyocytes for regenerative medicine. Kardiol Pol, 83(4), 417\u2013426. https:\/\/doi.org\/10.33963\/v.phj.104577","journal-title":"Kardiol Pol"},{"key":"11197_CR6","doi-asserted-by":"publisher","first-page":"100238","DOI":"10.1016\/j.crtox.2025","volume":"8","author":"X Gao","year":"2025","unstructured":"Gao, X., Li, R., Campasino, K., et al. (2025). Hepatocytes derived from human induced pluripotent stem cells: Towards establishing an in vitro model for assessing population variability in hepatotoxicity testing. Curr Res Toxicol, 8, 100238. https:\/\/doi.org\/10.1016\/j.crtox.2025","journal-title":"Curr Res Toxicol"},{"issue":"7","key":"11197_CR7","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2337\/db25-0037","volume":"74","author":"BJ Hering","year":"2025","unstructured":"Hering, B. J., Rickels, M. R., Bellin, M. D., et al. (2025). Advances in cell replacement therapies for diabetes. Diabetes, 74(7), 1068\u20131077. https:\/\/doi.org\/10.2337\/db25-0037","journal-title":"Diabetes"},{"key":"11197_CR8","doi-asserted-by":"publisher","unstructured":"Ogieuhi, I. J., Agbo, C. E., Ajekiigbe, V. O. (2025). Stem cell-derived pancreatic beta cells: a step closer to functional diabetes treatment? BMC Endocr Disord, 25(1):181. Published 2025 Jul 16. https:\/\/doi.org\/10.1186\/s12902-025-01997-y","DOI":"10.1186\/s12902-025-01997-y"},{"issue":"2","key":"11197_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","volume":"31","author":"MMA Verstegen","year":"2025","unstructured":"Verstegen, M. M. A., Coppes, R. P., Beghin, A., et al. (2025). Clinical applications of human organoids. Nature Medicine, 31(2), 409\u2013421. https:\/\/doi.org\/10.1038\/s41591-024-03489-3","journal-title":"Nature Medicine"},{"issue":"26","key":"11197_CR10","doi-asserted-by":"publisher","first-page":"7394","DOI":"10.1016\/j.cell.2024.10.044","volume":"187","author":"A Andersson-Rolf","year":"2024","unstructured":"Andersson-Rolf, A., Groot, K., Korving, J., et al. (2024). Long-term in vitro expansion of a human fetal pancreas stem cell that generates all three pancreatic cell lineages. Cell, 187(26), 7394\u20137413e22. https:\/\/doi.org\/10.1016\/j.cell.2024.10.044","journal-title":"Cell"},{"issue":"2","key":"11197_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.stemcr.2018.12.018","volume":"12","author":"K Nishihara","year":"2019","unstructured":"Nishihara, K., Shiga, T., Nakamura, E., et al. (2019). Induced pluripotent stem cells reprogrammed with three inhibitors show accelerated differentiation potentials with high levels of 2-cell stage marker expression. Stem Cell Reports, 12(2), 305\u2013318. https:\/\/doi.org\/10.1016\/j.stemcr.2018.12.018","journal-title":"Stem Cell Reports"},{"issue":"8044","key":"11197_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/d41586-024-04160-0","volume":"637","author":"A Abbott","year":"2025","unstructured":"Abbott, A. (2025). Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson\u2019s disease could soon be here. Nature, 637(8044), 18\u201320. https:\/\/doi.org\/10.1038\/d41586-024-04160-0","journal-title":"Nature"},{"issue":"6746","key":"11197_CR13","doi-asserted-by":"publisher","first-page":"eadp2959","DOI":"10.1126\/science.adp2959","volume":"388","author":"M G\u00f6tz","year":"2025","unstructured":"G\u00f6tz, M., & Torres-Padilla, M. E. (2025). Stem cells as role models for reprogramming and repair. Science, 388(6746), eadp2959. https:\/\/doi.org\/10.1126\/science.adp2959","journal-title":"Science"},{"issue":"11","key":"11197_CR14","doi-asserted-by":"publisher","first-page":"e70268","DOI":"10.1111\/acel.70268","volume":"24","author":"BK Jo","year":"2025","unstructured":"Jo, B. K., Lee, S. Y., Eom, H. J., Kim, J., & Cha, H. J. (2025). Organ-specific dedifferentiation and epigenetic remodeling in in vivo reprogramming. Aging Cell, 24(11), e70268. https:\/\/doi.org\/10.1111\/acel.70268","journal-title":"Aging Cell"},{"issue":"12","key":"11197_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41568-019-0213-x","volume":"19","author":"ED Williams","year":"2019","unstructured":"Williams, E. D., Gao, D., Redfern, A., & Thompson, E. W. (2019). Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nature Reviews Cancer, 19(12), 716\u2013732. https:\/\/doi.org\/10.1038\/s41568-019-0213-x","journal-title":"Nature Reviews Cancer"},{"key":"11197_CR16","doi-asserted-by":"publisher","unstructured":"Bhartiya, D., Jha, N., Tripathi, A., & Tripathi, A. Dysfunctional, tissue-resident, very small embryonic-like stem cells (VSELs) initiate cancer and result in its progression and metastasis, independent of epithelial-mesenchymal transition. Stem Cell Rev Rep. https:\/\/doi.org\/10.1007\/s12015-025-11003-6","DOI":"10.1007\/s12015-025-11003-6"},{"issue":"4","key":"11197_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s12015-024-10694-7","volume":"20","author":"D Bhartiya","year":"2024","unstructured":"Bhartiya, D., Raouf, S., Pansare, K., Tripathi, A., & Tripathi, A. (2024). Initiation of cancer: the journey from mutations in somatic cells to epigenetic changes in tissue-resident VSELs. Stem Cell Rev Rep, 20(4), 857\u2013880. https:\/\/doi.org\/10.1007\/s12015-024-10694-7","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"11197_CR18","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s12015-025-10880-1","volume":"21","author":"D Bhartiya","year":"2025","unstructured":"Bhartiya, D., Dutta, S., Tripathi, A., & Tripathi, A. (2025). Misconceptions thrive in the field of cancer as technological advances continue to confuse stem cell biology. Stem Cell Rev Rep, 21(5), 1471\u20131483. https:\/\/doi.org\/10.1007\/s12015-025-10880-1","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"11197_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/humupd\/dmaa058","volume":"27","author":"D Bhartiya","year":"2021","unstructured":"Bhartiya, D., Kausik, A., Singh, P., & Sharma, D. (2021). Will Single-Cell RNAseq decipher stem cells biology in normal and cancerous tissues? Human Reproduction Update, 27(2), 421. https:\/\/doi.org\/10.1093\/humupd\/dmaa058","journal-title":"Human Reproduction Update"},{"issue":"6","key":"11197_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s12015-017-9756-y","volume":"13","author":"D Bhartiya","year":"2017","unstructured":"Bhartiya, D. (2017). Pluripotent stem cells in adult tissues: Struggling to be acknowledged over two decades. Stem Cell Rev Rep, 13(6), 713\u2013724. https:\/\/doi.org\/10.1007\/s12015-017-9756-y","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"11197_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humupd\/dmw030","volume":"23","author":"D Bhartiya","year":"2016","unstructured":"Bhartiya, D., Shaikh, A., Anand, S., et al. (2016). Endogenous, very small embryonic-like stem cells: critical review, therapeutic potential and a look ahead. Human Reproduction Update, 23(1), 41\u201376. https:\/\/doi.org\/10.1093\/humupd\/dmw030","journal-title":"Human Reproduction Update"},{"key":"11197_CR22","doi-asserted-by":"publisher","first-page":"1061022","DOI":"10.3389\/fcell.2022.1061022","volume":"10","author":"D Bhartiya","year":"2023","unstructured":"Bhartiya, D., Jha, N., Tripathi, A., & Tripathi, A. (2023). Very small embryonic-like stem cells have the potential to win the three-front war on tissue damage, cancer, and aging. Front Cell Dev Biol, 10, 1061022. https:\/\/doi.org\/10.3389\/fcell.2022.1061022","journal-title":"Front Cell Dev Biol"},{"key":"11197_CR23","doi-asserted-by":"publisher","first-page":"1564964","DOI":"10.3389\/fbioe","volume":"13","author":"K Thetchinamoorthy","year":"2025","unstructured":"Thetchinamoorthy, K., Jarczak, J., Kieszek, P., et al. (2025). Very small embryonic-like stem cells (VSELs) on the way for potential applications in regenerative medicine. Frontiers In Bioengineering And Biotechnology, 13, 1564964. https:\/\/doi.org\/10.3389\/fbioe. Published 2025 Mar 7.","journal-title":"Frontiers In Bioengineering And Biotechnology"},{"issue":"5","key":"11197_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/sj.leu.2404171","volume":"20","author":"M Kucia","year":"2006","unstructured":"Kucia, M., Reca, R., Campbell, F. R., et al. (2006). A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4\u2009+\u2009stem cells identified in adult bone marrow. Leukemia, 20(5), 857\u2013869. https:\/\/doi.org\/10.1038\/sj.leu.2404171","journal-title":"Leukemia"},{"issue":"4","key":"11197_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"issue":"4","key":"11197_CR26","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s12015-026-11090-z","volume":"22","author":"D Bhartiya","year":"2026","unstructured":"Bhartiya, D., Sharma, N., Tripathi, A., & Tripathi, A. (2026). Tripotent Lgr5-positive progenitor stem cells co-exist with more primitive, pluripotent and quiescent VSELs. Stem Cell Rev Rep, 22(4), 2029\u20132032. https:\/\/doi.org\/10.1007\/s12015-026-11090-z","journal-title":"Stem Cell Rev Rep"},{"key":"11197_CR27","doi-asserted-by":"publisher","first-page":"102351","DOI":"10.1016\/j.gde.2025.102351","volume":"93","author":"MT Adams","year":"2025","unstructured":"Adams, M. T., Jasper, H., & Mosteiro, L. (2025). Unlocking regeneration: how partial reprogramming resembles tissue healing. Current Opinion In Genetics & Development, 93, 102351. https:\/\/doi.org\/10.1016\/j.gde.2025.102351","journal-title":"Current Opinion In Genetics & Development"},{"issue":"3","key":"11197_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tcb.2023.07.013","volume":"34","author":"A Huyghe","year":"2024","unstructured":"Huyghe, A., Trajkova, A., & Lavial, F. (2024). Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective. Trends In Cell Biology, 34(3), 255\u2013267. https:\/\/doi.org\/10.1016\/j.tcb.2023.07.013","journal-title":"Trends In Cell Biology"},{"issue":"1","key":"11197_CR29","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41467-024-46020-5","volume":"15","author":"AD Y\u00fccel","year":"2024","unstructured":"Y\u00fccel, A. D., & Gladyshev, V. N. (2024). The long and winding road of reprogramming-induced rejuvenation. Nature Communications, 15(1), 1941. https:\/\/doi.org\/10.1038\/s41467-024-46020-5","journal-title":"Nature Communications"},{"key":"11197_CR30","doi-asserted-by":"publisher","first-page":"101442","DOI":"10.1016\/j.preteyeres","volume":"111","author":"J Lee","year":"2026","unstructured":"Lee, J., Han, M., Wang, K., Butler, L. R., & Sinclair, D. A. (2026). Epigenetic reprogramming for ocular aging and disease: Mechanisms, biomarkers, and the road to the clinic. Progress In Retinal And Eye Research, 111, 101442. https:\/\/doi.org\/10.1016\/j.preteyeres2026.101442.","journal-title":"Progress In Retinal And Eye Research"},{"issue":"7471","key":"11197_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature12586","volume":"502","author":"M Abad","year":"2013","unstructured":"Abad, M., Mosteiro, L., Pantoja, C., et al. (2013). Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature, 502(7471), 340\u2013345. https:\/\/doi.org\/10.1038\/nature12586","journal-title":"Nature"},{"issue":"3","key":"11197_CR32","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cell.2025.12.025","volume":"189","author":"H Clevers","year":"2026","unstructured":"Clevers, H. (2026). Shifting paradigms in tissue stem cell biology: Insights from the intestine. Cell, 189(3), 706\u2013724. https:\/\/doi.org\/10.1016\/j.cell.2025.12.025","journal-title":"Cell"},{"issue":"6","key":"11197_CR33","doi-asserted-by":"publisher","first-page":"dmm052860","DOI":"10.1242\/dmm.052860","volume":"19","author":"H Clevers","year":"2026","unstructured":"Clevers, H. (2026). Gut instinct drives discovery: an interview with Hans Clevers. Dis Model Mech, 19(6), dmm052860. https:\/\/doi.org\/10.1242\/dmm.052860","journal-title":"Dis Model Mech"},{"issue":"4","key":"11197_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/stmcls\/sxad015","volume":"41","author":"D Bhartiya","year":"2023","unstructured":"Bhartiya, D., Sharma, N., Dutta, S., Kumar, P., Tripathi, A., & Tripathi, A. (2023). Very small embryonic-like stem cells transform into cancer stem cells and are novel candidates for detecting\/monitoring cancer by a simple blood test. Stem Cells, 41(4), 310\u2013318. https:\/\/doi.org\/10.1093\/stmcls\/sxad015","journal-title":"Stem Cells"},{"issue":"9","key":"11197_CR35","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/ncb0901-778","volume":"3","author":"JG Toma","year":"2001","unstructured":"Toma, J. G., Akhavan, M., Fernandes, K. J., Barnab\u00e9-Heider, F., Sadikot, A., et al. (2001). Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nature Cell Biology, 3(9), 778\u2013784. https:\/\/doi.org\/10.1038\/ncb0901-778","journal-title":"Nature Cell Biology"},{"issue":"6","key":"11197_CR36","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1634\/stemcells.2004-0134","volume":"23","author":"JG Toma","year":"2005","unstructured":"Toma, J. G., McKenzie, I. A., Bagli, D., & Miller, F. D. (2005). Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells, 23(6), 727\u2013737. https:\/\/doi.org\/10.1634\/stemcells.2004-0134","journal-title":"Stem Cells"},{"issue":"16","key":"11197_CR37","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.yexcr.2010.04.023","volume":"316","author":"K Okita","year":"2010","unstructured":"Okita, K., & Yamanaka, S. (2010). Induction of pluripotency by defined factors. Experimental Cell Research, 316(16), 2565\u20132570. https:\/\/doi.org\/10.1016\/j.yexcr.2010.04.023","journal-title":"Experimental Cell Research"},{"issue":"3","key":"11197_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cell.2005.02.018","volume":"121","author":"K Hochedlinger","year":"2005","unstructured":"Hochedlinger, K., Yamada, Y., Beard, C., & Jaenisch, R. (2005). Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell, 121(3), 465\u2013477. https:\/\/doi.org\/10.1016\/j.cell.2005.02.018","journal-title":"Cell"},{"issue":"1","key":"11197_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2217\/rme.09.81","volume":"5","author":"MM Daadi","year":"2010","unstructured":"Daadi, M. M. (2010). The common path: tumor suppression in the generation of iPS cells and cancer stem cells. Regenerative Medicine, 5(1), 21\u201322. https:\/\/doi.org\/10.2217\/rme.09.81","journal-title":"Regenerative Medicine"},{"issue":"5","key":"11197_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/embor.2010.47","volume":"11","author":"A Banito","year":"2010","unstructured":"Banito, A., & Gil, J. (2010). Induced pluripotent stem cells and senescence: learning the biology to improve the technology. Embo Reports, 11(5), 353\u2013359. https:\/\/doi.org\/10.1038\/embor.2010.47","journal-title":"Embo Reports"},{"issue":"24","key":"11197_CR41","doi-asserted-by":"publisher","first-page":"9875","DOI":"10.1073\/pnas.1100816108","volume":"108","author":"S Wakao","year":"2011","unstructured":"Wakao, S., Kitada, M., Kuroda, Y., et al. (2011). Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci U S A, 108(24), 9875\u20139880. https:\/\/doi.org\/10.1073\/pnas.1100816108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"11197_CR42","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1007\/s00018-012-0994-5","volume":"69","author":"M Kitada","year":"2012","unstructured":"Kitada, M., Wakao, S., & Dezawa, M. (2012). Muse cells and induced pluripotent stem cell: implication of the elite model. Cellular And Molecular Life Sciences, 69(22), 3739\u20133750. https:\/\/doi.org\/10.1007\/s00018-012-0994-5","journal-title":"Cellular And Molecular Life Sciences"},{"issue":"1","key":"11197_CR43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s13287-022-03126-1","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H., Wei, J., Liu, X., Zhang, P., & Lin, J. (2022). Muse cells: ushering in a new era of stem cell-based therapy for stroke. Stem Cell Research & Therapy, 13(1), 421. https:\/\/doi.org\/10.1186\/s13287-022-03126-1","journal-title":"Stem Cell Research & Therapy"},{"issue":"2","key":"11197_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12015-008-9017-1","volume":"4","author":"JE Trosko","year":"2008","unstructured":"Trosko, J. E., & Commentary (2008). Re-programming or selecting adult stem cells? Stem Cell Reviews, 4(2), 81\u201388. https:\/\/doi.org\/10.1007\/s12015-008-9017-1","journal-title":"Stem Cell Reviews"},{"key":"11197_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1354\/vp.46-2-176","volume":"46","author":"JE Trosko","year":"2009","unstructured":"Trosko, J. E. (2009). Cancer stem cells and cancer nonstem cells: from adult stem cells or from reprogramming of differentiated somatic cells. Veterinary Pathology, 46, 176\u2013193. https:\/\/doi.org\/10.1354\/vp.46-2-176","journal-title":"Veterinary Pathology"},{"issue":"1","key":"11197_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/ar.22793","volume":"297","author":"JE Trosko","year":"2014","unstructured":"Trosko, J. E. (2014). Induction of iPS cells and of cancer stem cells: the stem cell or reprogramming hypothesis of cancer? Anatomical Record (Hoboken), 297(1), 161\u2013173. https:\/\/doi.org\/10.1002\/ar.22793","journal-title":"Anatomical Record (Hoboken)"},{"issue":"Suppl 1","key":"11197_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2184.2008.00493.x","volume":"41","author":"S Yamanaka","year":"2008","unstructured":"Yamanaka, S. (2008). Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Proliferation, 41(Suppl 1), 51\u201356. https:\/\/doi.org\/10.1111\/j.1365-2184.2008.00493.x","journal-title":"Cell Proliferation"},{"issue":"3","key":"11197_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.bbrc.2004.02.093","volume":"316","author":"PW Dyce","year":"2004","unstructured":"Dyce, P. W., Zhu, H., Craig, J., & Li, J. (2004). Stem cells with multilineage potential derived from porcine skin. Biochemical And Biophysical Research Communications, 316(3), 651\u2013658. https:\/\/doi.org\/10.1016\/j.bbrc.2004.02.093","journal-title":"Biochemical And Biophysical Research Communications"},{"issue":"10","key":"11197_CR49","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/nm1009-1145","volume":"15","author":"S Yamanaka","year":"2009","unstructured":"Yamanaka, S. (2009). Ekiden to iPS Cells. Nature Medicine, 15(10), 1145\u20131148. https:\/\/doi.org\/10.1038\/nm1009-1145","journal-title":"Nature Medicine"},{"issue":"16","key":"11197_CR50","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.yexcr.2010.04.023","volume":"316","author":"K Okita","year":"2010","unstructured":"Okita, K., & Yamanaka, S. (2010). Induction of pluripotency by defined factors. Experimental Cell Research, 316(16), 2565\u20132570. https:\/\/doi.org\/10.1016\/j.yexcr.2010.04.023","journal-title":"Experimental Cell Research"},{"issue":"5889","key":"11197_CR51","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1126\/science.1154884","volume":"321","author":"T Aoi","year":"2008","unstructured":"Aoi, T., Yae, K., Nakagawa, M., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321(5889), 699\u2013702. https:\/\/doi.org\/10.1126\/science.1154884","journal-title":"Science"},{"issue":"2","key":"11197_CR52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2008.03.028","volume":"133","author":"J Hanna","year":"2008","unstructured":"Hanna, J., Markoulaki, S., Schorderet, P., Carey, B. W., Beard, C., et al. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell, 133(2), 250\u2013264. https:\/\/doi.org\/10.1016\/j.cell.2008.03.028","journal-title":"Cell"},{"issue":"12","key":"11197_CR53","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.cub.2008.05.010","volume":"18","author":"M Stadtfeld","year":"2008","unstructured":"Stadtfeld, M., Brennand, K., & Hochedlinger, K. (2008). Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Current Biology, 18(12), 890\u2013894. https:\/\/doi.org\/10.1016\/j.cub.2008.05.010","journal-title":"Current Biology"},{"issue":"30","key":"11197_CR54","doi-asserted-by":"publisher","first-page":"12172","DOI":"10.1073\/pnas.1310291110","volume":"110","author":"K Tanabe","year":"2013","unstructured":"Tanabe, K., Nakamura, M., Narita, M., Takahashi, K., & Yamanaka, S. (2013). Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts. Proc Natl Acad Sci U S A, 110(30), 12172\u201312179. https:\/\/doi.org\/10.1073\/pnas.1310291110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"11197_CR55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/cyto.a.22069","volume":"83","author":"S Wakao","year":"2013","unstructured":"Wakao, S., Kitada, M., & Dezawa, M. (2013). The elite and stochastic model for iPS cell generation: multilineage-differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells. Cytometry. Part A, 83(1), 18\u201326. https:\/\/doi.org\/10.1002\/cyto.a.22069","journal-title":"Cytometry. Part A"},{"issue":"1","key":"11197_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2010.06.003","volume":"7","author":"Seki","year":"2010","unstructured":"Seki, et al. (2010). Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell, 7(1), 11\u201314. [45].","journal-title":"Cell Stem Cell"},{"issue":"1","key":"11197_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.stem.2010.06.004","volume":"7","author":"Loh","year":"2010","unstructured":"Loh, et al. (2010). Reprogramming of T cells from human peripheral blood. Cell Stem Cell, 7(1), 15\u201319.","journal-title":"Cell Stem Cell"},{"issue":"22","key":"11197_CR58","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1182\/blood-2009-02-204800","volume":"113","author":"Loh","year":"2009","unstructured":"Loh, et al. (2009). Generation of induced pluripotent stem cells from human blood. Blood, 113(22), 5476\u20135479.","journal-title":"Blood"},{"issue":"30","key":"11197_CR59","doi-asserted-by":"publisher","first-page":"12172","DOI":"10.1073\/pnas.1310291110","volume":"110","author":"Tanabe","year":"2013","unstructured":"Tanabe, et al. (2013). Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts. Proc Natl Acad Sci U S A, 110(30), 12172\u201312179.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"11197_CR60","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.gpb.2013.08.002","volume":"11","author":"Wang","year":"2013","unstructured":"Wang, et al. (2013). Generation of induced pluripotent stem cells with high efficiency from human umbilical cord blood mononuclear cells. Genomics Proteomics Bioinformatics, 11(5), 304\u2013311.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"6","key":"11197_CR61","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.tibs.2025.03.004","volume":"50","author":"L Cheng","year":"2025","unstructured":"Cheng, L., Wang, Y., Guan, J., & Deng, H. (2025). Decoding human chemical reprogramming: mechanisms and principles. Trends In Biochemical Sciences, 50(6), 520\u2013531. https:\/\/doi.org\/10.1016\/j.tibs.2025.03.004","journal-title":"Trends In Biochemical Sciences"},{"issue":"7","key":"11197_CR62","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s41589-024-01799-8","volume":"21","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Peng, F., Yang, Z., et al. (2025). A rapid chemical reprogramming system to generate human pluripotent stem cells. Nature Chemical Biology, 21(7), 1030\u20131038. https:\/\/doi.org\/10.1038\/s41589-024-01799-8","journal-title":"Nature Chemical Biology"},{"issue":"6146","key":"11197_CR63","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1126\/science.1239278","volume":"341","author":"P Hou","year":"2013","unstructured":"Hou, P., Li, Y., Zhang, X., et al. (2013). Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science, 341(6146), 651\u2013654. https:\/\/doi.org\/10.1126\/science.1239278","journal-title":"Science"},{"issue":"12","key":"11197_CR64","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/cr.2013.119","volume":"23","author":"A De Los Angeles","year":"2013","unstructured":"De Los Angeles, A., & Daley, G. Q. (2013). A chemical logic for reprogramming to pluripotency. Cell Research, 23(12), 1337\u20131338. https:\/\/doi.org\/10.1038\/cr.2013.119","journal-title":"Cell Research"},{"issue":"8","key":"11197_CR65","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.stem.2025.07.003","volume":"32","author":"F Peng","year":"2025","unstructured":"Peng, F., Wang, Y., Cheng, L., et al. (2025). Chemical reprogramming of human blood cells to pluripotent stem cells. Cell Stem Cell, 32(8), 1192\u20131199e11. https:\/\/doi.org\/10.1016\/j.stem.2025.07.003","journal-title":"Cell Stem Cell"},{"issue":"7","key":"11197_CR66","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s41589-024-01799-8","volume":"21","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Peng, F., Yang, Z., et al. (2025). A rapid chemical reprogramming system to generate human pluripotent stem cells. Nature Chemical Biology, 21(7), 1030\u20131038. https:\/\/doi.org\/10.1038\/s41589-024-01799-8","journal-title":"Nature Chemical Biology"},{"issue":"1","key":"11197_CR67","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/CIRCRESAHA.116.309362","volume":"120","author":"MZ Ratajczak","year":"2017","unstructured":"Ratajczak, M. Z., Ratajczak, J., Suszynska, M., Miller, D. M., Kucia, M., & Shin, D. M. (2017). A novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem Cells. Circ Res, 120(1), 166\u2013178. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309362","journal-title":"Circ Res"},{"issue":"4","key":"11197_CR68","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12015-018-9821-1","volume":"14","author":"R Lahlil","year":"2018","unstructured":"Lahlil, R., Scrofani, M., Barbet, R., Tancredi, C., Aries, A., & H\u00e9non, P. (2018). VSELs maintain their pluripotency and competence to differentiate after enhanced ex vivo expansion. Stem Cell Rev Rep, 14(4), 510\u2013524. https:\/\/doi.org\/10.1007\/s12015-018-9821-1","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"11197_CR69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41556-023-01334-2","volume":"26","author":"HH Ng","year":"2024","unstructured":"Ng, H. H. (2024). Orphan nuclear receptors joining the reprogramming club. Nature Cell Biology, 26(2), 171. https:\/\/doi.org\/10.1038\/s41556-023-01334-2","journal-title":"Nature Cell Biology"},{"issue":"8","key":"11197_CR70","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/leu.2017.148","volume":"31","author":"MZ Ratajczak","year":"2017","unstructured":"RatajczakMZ (2017). Why are hematopoietic stem cells so \u2018sexy\u2019? on a search for developmental explanation. Leukemia, 31(8), 1671\u20131677. https:\/\/doi.org\/10.1038\/leu.2017.148","journal-title":"Leukemia"},{"issue":"10","key":"11197_CR71","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.5966\/sctm.2014-0090","volume":"3","author":"Y Yamada","year":"2014","unstructured":"Yamada, Y., Haga, H., & Yamada, Y. (2014). Concise review: dedifferentiation meets cancer development: proof of concept for epigenetic cancer. Stem Cells Transl Med, 3(10), 1182\u20131187. https:\/\/doi.org\/10.5966\/sctm.2014-0090","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"11197_CR72","doi-asserted-by":"publisher","first-page":"105553","DOI":"10.1016\/j.esmoop","volume":"10","author":"F Andr\u00e9","year":"2025","unstructured":"Andr\u00e9, F., Rassy, E., Achutti-Duso, B., et al. (2025). The rising tides of cancers among young adults. ESMO Open, 10(9), 105553. https:\/\/doi.org\/10.1016\/j.esmoop2025.105553.","journal-title":"ESMO Open"},{"issue":"3","key":"11197_CR73","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/embr.201338254","volume":"15","author":"D Friedmann-Morvinski","year":"2014","unstructured":"Friedmann-Morvinski, D., & Verma, I. M. (2014). Dedifferentiation and reprogramming: origins of cancer stem cells. Embo Reports, 15(3), 244\u2013253. https:\/\/doi.org\/10.1002\/embr.201338254","journal-title":"Embo Reports"},{"key":"11197_CR74","doi-asserted-by":"publisher","first-page":"16105","DOI":"10.1038\/cddiscovery.2016.105","volume":"3","author":"P Wang","year":"2017","unstructured":"Wang, P., Wan, W. W., Xiong, S. L., Feng, H., & Wu, N. (2017). Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death Discov, 3, 16105. https:\/\/doi.org\/10.1038\/cddiscovery.2016.105","journal-title":"Cell Death Discov"},{"issue":"13","key":"11197_CR75","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1038\/s44318-024-00099-0","volume":"43","author":"CJ Cho","year":"2024","unstructured":"Cho, C. J., Brown, J. W., & Mills, J. C. (2024). Origins of cancer: Ain\u2019t it just mature cells misbehaving? Embo Journal, 43(13), 2530\u20132551. https:\/\/doi.org\/10.1038\/s44318-024-00099-0","journal-title":"Embo Journal"},{"key":"11197_CR76","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-physiol-061121-035954","volume":"84","author":"JW Brown","year":"2022","unstructured":"Brown, J. W., Cho, C. J., Mills, J. C., & Paligenosis (2022). Cellular remodeling during tissue repair. Annual Review Of Physiology, 84, 461\u2013483. https:\/\/doi.org\/10.1146\/annurev-physiol-061121-035954","journal-title":"Annual Review Of Physiology"},{"issue":"1","key":"11197_CR77","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13046-025-03501-9","volume":"44","author":"C Clemente-Gonz\u00e1lez","year":"2025","unstructured":"Clemente-Gonz\u00e1lez, C., & Carnero, A. (2025). Tfcp2l1 as a central integrator of hypoxia, dedifferentiation, and tumor progression. Journal Of Experimental & Clinical Cancer Research : Cr, 44(1), 236. https:\/\/doi.org\/10.1186\/s13046-025-03501-9","journal-title":"Journal Of Experimental & Clinical Cancer Research : Cr"},{"key":"11197_CR78","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fonc.2015.00155","volume":"5","author":"MK Jolly","year":"2015","unstructured":"Jolly, M. K., Boareto, M., Huang, B., et al. (2015). Implications of the hybrid epithelial\/ mesenchymal phenotype in metastasis. Frontiers In Oncology, 5, 155. https:\/\/doi.org\/10.3389\/fonc.2015.00155","journal-title":"Frontiers In Oncology"},{"key":"11197_CR79","doi-asserted-by":"publisher","first-page":"101226","DOI":"10.1016\/j.blre.2024.101226","volume":"68","author":"Q Shen","year":"2024","unstructured":"Shen, Q., Gong, X., Feng, Y., et al. (2024). Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways? Blood Reviews, 68, 101226. https:\/\/doi.org\/10.1016\/j.blre.2024.101226","journal-title":"Blood Reviews"},{"issue":"6","key":"11197_CR80","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41375-024-02252-4","volume":"38","author":"J Chen","year":"2024","unstructured":"Chen, J., Gale, R. P., Hu, Y., Yan, W., Wang, T., & Zhang, W. (2024). Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia, 38(6), 1202\u20131212. https:\/\/doi.org\/10.1038\/s41375-024-02252-4","journal-title":"Leukemia"},{"key":"11197_CR81","doi-asserted-by":"publisher","first-page":"1446687","DOI":"10.3389\/fimmu.2024.1446687","volume":"15","author":"A Kr\u0119towska-Grunwald","year":"2024","unstructured":"Kr\u0119towska-Grunwald, A., Sawicka-\u017bukowska, M., Starosz, A., Krawczuk-Rybak, M., Moniuszko, M., & Grubczak, K. (2024). Selected stem cell populations in pediatric acute lymphoblastic leukemia. Frontiers In Immunology, 15, 1446687. https:\/\/doi.org\/10.3389\/fimmu.2024.1446687","journal-title":"Frontiers In Immunology"},{"issue":"23","key":"11197_CR82","doi-asserted-by":"publisher","first-page":"16671","DOI":"10.3390\/ijms242316671","volume":"24","author":"R Lahlil","year":"2023","unstructured":"Lahlil, R., Aries, A., Scrofani, M., Zanetti, C., Hennequin, D., & Dr\u00e9nou, B. (2023). Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia. International Journal Of Molecular Sciences, 24(23), 16671. https:\/\/doi.org\/10.3390\/ijms242316671","journal-title":"International Journal Of Molecular Sciences"},{"issue":"2","key":"11197_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.0959-9673.2005.00421.x","volume":"86","author":"LP Bignold","year":"2005","unstructured":"Bignold, L. P. (2005). Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability. International Journal Of Experimental Pathology, 86(2), 67\u201379. https:\/\/doi.org\/10.1111\/j.0959-9673.2005.00421.x","journal-title":"International Journal Of Experimental Pathology"},{"issue":"5","key":"11197_CR84","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.124.070136","volume":"150","author":"EN Olson","year":"2024","unstructured":"Olson, E. N. (2024). Myocardial regeneration: Feasible or fantasy? Circulation, 150(5), 347\u2013349. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070136","journal-title":"Circulation"},{"issue":"3","key":"11197_CR85","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41587-019-0042-1","volume":"37","author":"KR Chien","year":"2019","unstructured":"Chien, K. R., Fris\u00e9n, J., Fritsche-Danielson, R., Melton, D. A., Murry, C. E., & Weissman, I. L. (2019). Regenerating the field of cardiovascular cell therapy. Nature Biotechnology, 37(3), 232\u2013237. https:\/\/doi.org\/10.1038\/s41587-019-0042-1","journal-title":"Nature Biotechnology"},{"issue":"4","key":"11197_CR86","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.devcel.2022.01.012","volume":"57","author":"JC Garbern","year":"2022","unstructured":"Garbern, J. C., & Lee, R. T. (2022). Heart regeneration: 20 years of progress and renewed optimism. Developmental Cell, 57(4), 424\u2013439. https:\/\/doi.org\/10.1016\/j.devcel.2022.01.012","journal-title":"Developmental Cell"},{"issue":"5","key":"11197_CR87","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41569-024-01098-8","volume":"22","author":"JJ Zhang","year":"2025","unstructured":"Zhang, J. J., Pogwizd, S. M., Fukuda, K., et al. (2025). Trials and tribulations of cell therapy for heart failure: an update on ongoing trials. Nature Reviews. Cardiology, 22(5), 372\u2013385. https:\/\/doi.org\/10.1038\/s41569-024-01098-8","journal-title":"Nature Reviews. Cardiology"},{"issue":"7","key":"11197_CR88","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.3390\/ijms26073063","volume":"26","author":"M Almeida","year":"2025","unstructured":"Almeida, M., In\u00e1cio, J. M., Vital, C. M., Rodrigues, M. R., Ara\u00fajo, B. C., & Belo, J. A. (2025). Cell reprogramming, transdifferentiation, and dedifferentiation approaches for heart repair. International Journal Of Molecular Sciences, 26(7), 3063. https:\/\/doi.org\/10.3390\/ijms26073063","journal-title":"International Journal Of Molecular Sciences"},{"issue":"10","key":"11197_CR89","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1038\/s12276-025-01549-3","volume":"57","author":"RMI Karim Rony","year":"2025","unstructured":"Karim Rony, R. M. I., & Tompkins, J. D. (2025). Cardiac repair and regeneration: cell therapy, in vivo reprogramming, and the promise of extracellular vesicles. Experimental & Molecular Medicine, 57(10), 2182\u20132200. https:\/\/doi.org\/10.1038\/s12276-025-01549-3","journal-title":"Experimental & Molecular Medicine"},{"issue":"22","key":"11197_CR90","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/healthcare13222937","volume":"13","author":"DH An","year":"2025","unstructured":"An, D. H. (2025). CVD mortality disparities with risk factor associations across US counties. Healthcare (Basel), 13(22), 2937. https:\/\/doi.org\/10.3390\/healthcare13222937","journal-title":"Healthcare (Basel)"},{"issue":"13","key":"11197_CR91","doi-asserted-by":"publisher","first-page":"e038644","DOI":"10.1161\/JAHA.124.038644","volume":"14","author":"SJ King","year":"2025","unstructured":"King, S. J., Wangdak Yuthok, T. Y., Bacong, A. M., et al. (2025). Heart disease mortality in the United States, 1970 to 2022. J Am Heart Assoc, 14(13), e038644. https:\/\/doi.org\/10.1161\/JAHA.124.038644","journal-title":"J Am Heart Assoc"},{"key":"11197_CR92","doi-asserted-by":"publisher","unstructured":"Kazi, D. S., Abdullah, A. R., Arnold, S. V. 2025 AHA\/ACC Statement on cost\/value methodology in clinical practice guidelines (update from 2014 statement): a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2025.05.009","DOI":"10.1016\/j.jacc.2025.05.009"},{"issue":"5","key":"11197_CR93","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.124.070136","volume":"150","author":"EN Olson","year":"2024","unstructured":"Olson, E. N. (2024). Myocardial regeneration: Feasible or fantasy? Circulation, 150(5), 347\u2013349. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070136","journal-title":"Circulation"},{"key":"11197_CR94","doi-asserted-by":"publisher","unstructured":"Xu, Y., Yan, Z., Li, N., Tang, J., & Xu, Z. New visions and research trends in fetal-originated adult cardiovascular and metabolic diseases. Drug Discov Today. https:\/\/doi.org\/10.1016\/j.drudis.2025.104517","DOI":"10.1016\/j.drudis.2025.104517"},{"issue":"4","key":"11197_CR95","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/jdi.12061","volume":"4","author":"K Minami","year":"2013","unstructured":"Minami, K. (2013). Searching for stem cells in the adult pancreas: A futile effort? J Diabetes Investig, 4(4), 331\u2013333. https:\/\/doi.org\/10.1111\/jdi.12061","journal-title":"J Diabetes Investig"},{"issue":"11","key":"11197_CR96","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.stem.2021.07.004","volume":"28","author":"SC Lodestijn","year":"2021","unstructured":"Lodestijn, S. C., van den Bosch, T., Nijman, L. E., et al. (2021). Continuous clonal labeling reveals uniform progenitor potential in the adult exocrine pancreas. Cell Stem Cell, 28(11), 2009\u20132019e4. https:\/\/doi.org\/10.1016\/j.stem.2021.07.004","journal-title":"Cell Stem Cell"},{"key":"11197_CR97","doi-asserted-by":"publisher","first-page":"1521411","DOI":"10.3389\/fcell.2025.1521411","volume":"13","author":"K Jacques","year":"2025","unstructured":"Jacques, K., Coles, B. L. K., & van der Kooy, D. (2025). Pancreatic stem cells originate during the pancreatic progenitor developmental stage. Front Cell Dev Biol, 13, 1521411. https:\/\/doi.org\/10.3389\/fcell.2025.1521411","journal-title":"Front Cell Dev Biol"},{"key":"11197_CR98","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H., Saeedi, P., Karuranga, S., et al. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research And Clinical Practice, 183, 109119. https:\/\/doi.org\/10.1016\/j.diabres.2021","journal-title":"Diabetes Research And Clinical Practice"},{"issue":"6","key":"11197_CR99","doi-asserted-by":"publisher","first-page":"e2096","DOI":"10.1210\/clinem\/dgae624","volume":"110","author":"J Son","year":"2025","unstructured":"Son, J., & Accili, D. (2025). Dedifferentiation as a stealthy disruptor of \u03b2-cell function in diabetes. Journal Of Clinical Endocrinology And Metabolism, 110(6), e2096\u2013e2097. https:\/\/doi.org\/10.1210\/clinem\/dgae624","journal-title":"Journal Of Clinical Endocrinology And Metabolism"},{"key":"11197_CR100","doi-asserted-by":"publisher","first-page":"1414447","DOI":"10.3389\/fendo.2024.1414447","volume":"15","author":"S Patel","year":"2024","unstructured":"Patel, S., & Remedi, M. S. (2024). Loss of \u03b2-cell identity and dedifferentiation, not an irreversible process? Front Endocrinol (Lausanne), 15, 1414447. https:\/\/doi.org\/10.3389\/fendo.2024.1414447","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"11197_CR101","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1007\/s00125-025-06499-z","volume":"68","author":"B Yau","year":"2025","unstructured":"Yau, B., Ghislain, J., Kebede, M. A., Hughes, J., & Poitout, V. (2025). The role of the beta cell in type 2 diabetes: New findings from the last 5 years. Diabetologia, 68(10), 2092\u20132103. https:\/\/doi.org\/10.1007\/s00125-025-06499-z","journal-title":"Diabetologia"},{"key":"11197_CR102","doi-asserted-by":"publisher","first-page":"1414447","DOI":"10.3389\/fendo.2024.1414447","volume":"15","author":"S Patel","year":"2024","unstructured":"Patel, S., & Remedi, M. S. (2024). Loss of \u03b2-cell identity and dedifferentiation, not an irreversible process? Frontiers In Endocrinology, 15, 1414447. https:\/\/doi.org\/10.3389\/fendo.2024.1414447","journal-title":"Frontiers In Endocrinology"},{"issue":"6","key":"11197_CR103","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","volume":"150","author":"C Talchai","year":"2012","unstructured":"Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012). Pancreatic \u03b2 cell dedifferentiation as a mechanism of diabetic \u03b2 cell failure. Cell, 150(6), 1223\u20131234. https:\/\/doi.org\/10.1016\/j.cell.2012.07.029","journal-title":"Cell"},{"issue":"3","key":"11197_CR104","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1210\/jc.2015-2860","volume":"101","author":"F Cinti","year":"2016","unstructured":"Cinti, F., Bouchi, R., Kim-Muller, J. Y., et al. (2016). Evidence of \u03b2-Cell Dedifferentiation in Human Type 2 Diabetes. Journal Of Clinical Endocrinology And Metabolism, 101(3), 1044\u20131054. https:\/\/doi.org\/10.1210\/jc.2015-2860","journal-title":"Journal Of Clinical Endocrinology And Metabolism"},{"key":"11197_CR105","doi-asserted-by":"publisher","first-page":"1587893","DOI":"10.3389\/fcell.2025.1587893","volume":"13","author":"Y Dor","year":"2025","unstructured":"Dor, Y., & Spitzer, N. C. (2025). Hormone-switching islet cells: parallels to transmitter-switching neurons. Front Cell Dev Biol, 13, 1587893. https:\/\/doi.org\/10.3389\/fcell.2025.1587893","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"11197_CR106","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.1038\/s41467-025-62670-5","volume":"16","author":"RB Kang","year":"2025","unstructured":"Kang, R. B., Varela, M., Oh, E., et al. (2025). Human pancreatic \u03b1-cell heterogeneity and trajectory inference analyses reveal SMOC1 as a \u03b2-cell dedifferentiation gene. Nature Communications, 16(1), 8434. https:\/\/doi.org\/10.1038\/s41467-025-62670-5","journal-title":"Nature Communications"},{"key":"11197_CR107","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/sj.leu.2403796","volume":"19","author":"M Kucia","year":"2005","unstructured":"Kucia, M., Reca, R., Jala, V. R., Dawn, B., Ratajczak, J., & Ratajczak, M. Z. (2005). Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia, 19, 1118\u20131127. https:\/\/doi.org\/10.1038\/sj.leu.2403796","journal-title":"Leukemia"},{"issue":"6","key":"11197_CR108","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s12015-017-9756-y","volume":"13","author":"D Bhartiya","year":"2017","unstructured":"Bhartiya, D. (2017). Pluripotent stem cells in adult tissues: struggling to be acknowledged over two decades. Stem Cell Rev Rep, 13(6), 713\u2013724. https:\/\/doi.org\/10.1007\/s12015-017-9756-y","journal-title":"Stem Cell Rev Rep"},{"issue":"12","key":"11197_CR109","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1038\/s41375-018-0294-7","volume":"32","author":"MZ Ratajczak","year":"2018","unstructured":"Ratajczak, M. Z., Bujko, K., Mack, A., Kucia, M., & Ratajczak, J. (2018). Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms. Leukemia, 32(12), 2519\u20132526. https:\/\/doi.org\/10.1038\/s41375-018-0294-7","journal-title":"Leukemia"},{"key":"11197_CR110","doi-asserted-by":"publisher","unstructured":"Virant-Klun, I., & Stimpfel, M. (2016). Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer. Sci Rep, 6:34730. Published 2016 Oct 5. https:\/\/doi.org\/10.1038\/srep34730","DOI":"10.1038\/srep34730"},{"key":"11197_CR111","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13048-016-0221-3","volume":"9","author":"I Virant-Klun","year":"2016","unstructured":"Virant-Klun, I., Kenda-Suster, N., Smrkolj, S., & Small putative, N. A. N. O. G. (2016). SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer. J Ovarian Res, 9, 12. https:\/\/doi.org\/10.1186\/s13048-016-0221-3","journal-title":"J Ovarian Res"},{"issue":"8","key":"11197_CR112","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1007\/s12015-022-10424-x","volume":"18","author":"D Bhartiya","year":"2022","unstructured":"Bhartiya, D., Kaushik, A., Singh, P., & Sharma, D. (2022). Cancer initiates due to excessive self-renewal and blocked differentiation of tissue-resident, OCT-4 positive VSELs. Stem Cell Rev Rep, 18(8), 3112\u20133114. https:\/\/doi.org\/10.1007\/s12015-022-10424-x","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"11197_CR113","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1007\/s12015-022-10367-3","volume":"18","author":"P Singh","year":"2022","unstructured":"Singh, P., & Bhartiya, D. (2022). Molecular insights into endometrial cancer in mice. Stem Cell Rev Rep, 18(5), 1702\u20131717. https:\/\/doi.org\/10.1007\/s12015-022-10367-3","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"11197_CR114","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1530\/REP-22-0337","volume":"165","author":"P Singh","year":"2023","unstructured":"Singh, P., & Bhartiya, D. (2023). Mouse uterine stem cells are affected by endocrine disruption and initiate uteropathies. Reproduction, 165(3), 249\u2013268. https:\/\/doi.org\/10.1530\/REP-22-0337","journal-title":"Reproduction"},{"issue":"1","key":"11197_CR115","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13287-022-02784-5","volume":"13","author":"A Kaushik","year":"2022","unstructured":"Kaushik, A., & Bhartiya, D. (2022). Testicular cancer in mice: interplay between stem cells and endocrine insults. Stem Cell Research & Therapy, 13(1), 243. https:\/\/doi.org\/10.1186\/s13287-022-02784-5","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"11197_CR116","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s43032-020-00250-2","volume":"28","author":"P Singh","year":"2021","unstructured":"Singh, P., & Bhartiya, D. (2021). Pluripotent stem (VSELs) and progenitor (EnSCs) cells exist in adult mouse uterus and show cyclic changes across estrus cycle. Reprod Sci, 28(1), 278\u2013290. https:\/\/doi.org\/10.1007\/s43032-020-00250-2","journal-title":"Reprod Sci"},{"issue":"5","key":"11197_CR117","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s12015-020-09993-6","volume":"16","author":"A Kaushik","year":"2020","unstructured":"Kaushik, A., & Bhartiya, D. (2020). Additional evidence to establish existence of two stem cell populations including VSELs and SSCs in adult mouse testes. Stem Cell Rev Rep, 16(5), 992\u20131004. https:\/\/doi.org\/10.1007\/s12015-020-09993-6","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"11197_CR118","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s12015-021-10237-4","volume":"17","author":"D Sharma","year":"2021","unstructured":"Sharma, D., & Bhartiya, D. (2021). Stem cells in adult mice ovaries form germ cell nests, undergo meiosis, neo-oogenesis and follicle assembly on regular basis during estrus cycle. Stem Cell Rev Rep, 17(5), 1695\u20131711. https:\/\/doi.org\/10.1007\/s12015-021-10237-4","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"11197_CR119","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13048-021-00883-0","volume":"14","author":"D Bhartiya","year":"2021","unstructured":"Bhartiya, D., Patel, H., Kaushik, A., Singh, P., & Sharma, D. (2021). Endogenous, tissue-resident stem\/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-3. J Ovarian Res, 14(1), 145. https:\/\/doi.org\/10.1186\/s13048-021-00883-0","journal-title":"J Ovarian Res"},{"issue":"1","key":"11197_CR120","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/jclinpath-2017-204815","volume":"71","author":"B van Schaijik","year":"2018","unstructured":"van Schaijik, B., Davis, P. F., Wickremesekera, A. C., Tan, S. T., & Itinteang, T. (2018). Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review. Journal Of Clinical Pathology, 71(1), 88\u201391. https:\/\/doi.org\/10.1136\/jclinpath-2017-204815","journal-title":"Journal Of Clinical Pathology"},{"key":"11197_CR121","doi-asserted-by":"publisher","unstructured":"Siraj, A., Desestret, V., Antoine, M. (2013). Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases. BMC Cancer, 13:246. Published 2013 May 20. https:\/\/doi.org\/10.1186\/1471-2407-13-246","DOI":"10.1186\/1471-2407-13-246"},{"issue":"1","key":"11197_CR122","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12916-018-1157-9","volume":"16","author":"C Fiala","year":"2018","unstructured":"Fiala, C., & EP Diamandis (2018). Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection. Bmc Medicine, 16(1), 166. https:\/\/doi.org\/10.1186\/s12916-018-1157-9. Published 2018 Oct 2.","journal-title":"Bmc Medicine"},{"issue":"4","key":"11197_CR123","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1515\/cclm-2018-1249","volume":"57","author":"C Fiala","year":"2019","unstructured":"Fiala, C., & Diamandis, E. P. (2019). Can Grail find the trail to early cancer detection? Clinical Chemistry And Laboratory Medicine, 57(4), 403\u2013406. https:\/\/doi.org\/10.1515\/cclm-2018-1249","journal-title":"Clinical Chemistry And Laboratory Medicine"},{"issue":"2","key":"11197_CR124","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s12015-021-10119-9","volume":"17","author":"D Bhartiya","year":"2021","unstructured":"Bhartiya, D., Flora, Y., Sharma, D., & Mohammad, S. A. (2021). Two stem cell populations including VSELs and CSCs detected in the pericardium of adult mouse heart. Stem Cell Rev Rep, 17(2), 685\u2013693. https:\/\/doi.org\/10.1007\/s12015-021-10119-9","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"11197_CR125","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12015-019-09923-1","volume":"16","author":"M El-Helw","year":"2020","unstructured":"El-Helw, M., Chelvarajan, L., Abo-Aly, M., et al. (2020). Identification of human very small embryonic like stem cells (VSELs) in human heart tissue among young and old individuals. Stem Cell Rev Rep, 16(1), 181\u2013185. https:\/\/doi.org\/10.1007\/s12015-019-09923-1","journal-title":"Stem Cell Rev Rep"},{"issue":"12","key":"11197_CR126","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.exphem.2010.08.003","volume":"38","author":"A Abdel-Latif","year":"2010","unstructured":"Abdel-Latif, A., Zuba-Surma, E. K., Ziada, K. M., et al. (2010). Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia. Experimental Hematology, 38(12), 1131\u20131142e1. https:\/\/doi.org\/10.1016\/j.exphem.2010.08.003","journal-title":"Experimental Hematology"},{"issue":"10","key":"11197_CR127","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/leu.2010.181","volume":"24","author":"MZ Ratajczak","year":"2010","unstructured":"Ratajczak, M. Z. (2010). Spotlight series on stem cell mobilization: many hands on the ball, but who is the quarterback? Leukemia, 24(10), 1665\u20131666. https:\/\/doi.org\/10.1038\/leu.2010.181","journal-title":"Leukemia"},{"key":"11197_CR128","doi-asserted-by":"publisher","unstructured":"Bhartiya, D., Mundekar, A., Mahale, V., & Patel, H. (2014). Very small embryonic-like stem cells are involved in regeneration of mouse pancreas post-pancreatectomy. Stem Cell Res Ther, 5(5):106. Published 2014 Sep 2. https:\/\/doi.org\/10.1186\/scrt494","DOI":"10.1186\/scrt494"},{"issue":"1","key":"11197_CR129","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12015-019-09919-x","volume":"16","author":"SA Mohammad","year":"2020","unstructured":"Mohammad, S. A., Metkari, S., & Bhartiya, D. (2020). Mouse pancreas stem\/progenitor cells get augmented by streptozotocin and regenerate diabetic pancreas after partial pancreatectomy. Stem Cell Rev Rep, 16(1), 144\u2013158. https:\/\/doi.org\/10.1007\/s12015-019-09919-x","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"11197_CR130","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","volume":"10","author":"X Han","year":"2025","unstructured":"Han, X., Liao, R., Li, X., et al. (2025). Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target Ther, 10(1), 262. https:\/\/doi.org\/10.1038\/s41392-025-02313-9","journal-title":"Signal Transduct Target Ther"},{"key":"11197_CR131","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jare.2024.05.004","volume":"70","author":"CM Trigo","year":"2025","unstructured":"Trigo, C. M., Rodrigues, J. S., Cam\u00f5es, S. P., Sol\u00e1, S., & Miranda, J. P. (2025). Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? Journal Of Advanced Research, 70, 103\u2013124. https:\/\/doi.org\/10.1016\/j.jare.2024.05.004","journal-title":"Journal Of Advanced Research"},{"issue":"1","key":"11197_CR132","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s43556-025-00277-4","volume":"6","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Wang, H., Tan, J., et al. (2025). Therapeutic effect of mesenchymal stem cells and their derived exosomes in diseases. Mol Biomed, 6(1), 34. https:\/\/doi.org\/10.1186\/s43556-025-00277-4","journal-title":"Mol Biomed"},{"issue":"3","key":"11197_CR133","doi-asserted-by":"publisher","first-page":"e70000","DOI":"10.1002\/btm2.70000","volume":"10","author":"S Acharya","year":"2025","unstructured":"Acharya, S., Shaha, S., Bibbey, M. G., Mukherji, M., Zhao, Z., & Mitragotri, S. (2025). Stem cell therapies in the clinic. Bioeng Transl Med, 10(3), e70000. https:\/\/doi.org\/10.1002\/btm2.70000","journal-title":"Bioeng Transl Med"},{"issue":"6","key":"11197_CR134","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/sctm.17-0051","volume":"6","author":"AI Caplan","year":"2017","unstructured":"Caplan, A. I. (2017). Mesenchymal Stem Cells: Time to Change the Name! Stem Cells Transl Med, 6(6), 1445\u20131451. https:\/\/doi.org\/10.1002\/sctm.17-0051","journal-title":"Stem Cells Transl Med"},{"key":"11197_CR135","doi-asserted-by":"publisher","unstructured":"Nakamura, K. (2025). Key mediators of the efficacy of mesenchymal stem cells on in vivo disease models. Cell Transplantation, 34. https:\/\/doi.org\/10.1177\/09636897251348566","DOI":"10.1177\/09636897251348566"},{"issue":"6","key":"11197_CR136","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1016\/j.ymthe","volume":"33","author":"W Lu","year":"2025","unstructured":"Lu, W., & Allickson, J. (2025). Mesenchymal stromal cell therapy: Progress to date and future outlook. Molecular Therapy, 33(6), 2679\u20132688. https:\/\/doi.org\/10.1016\/j.ymthe2025.02.003.","journal-title":"Molecular Therapy"},{"key":"11197_CR137","doi-asserted-by":"publisher","first-page":"1824475","DOI":"10.3389\/fcell.2026.1824475","volume":"14","author":"A Etzenberger","year":"2026","unstructured":"Etzenberger, A., & Hernandez, D. (2026). Limitations in the clinical translation of mesenchymal stromal cells: standardisation, heterogeneity and the recipient. Front Cell Dev Biol, 14, 1824475. https:\/\/doi.org\/10.3389\/fcell.2026.1824475","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"11197_CR138","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s12015-026-11068-x","volume":"22","author":"G Antonio-R\u00edos","year":"2026","unstructured":"Antonio-R\u00edos, G., Ribas-Aparicio, R. M., Leyva-G\u00f3mez, G., et al. (2026). The impact of large-scale expansion on the functional properties of mesenchymal stem cells. Stem Cell Rev Rep, 22(3), 1051\u20131066. https:\/\/doi.org\/10.1007\/s12015-026-11068-x","journal-title":"Stem Cell Rev Rep"},{"key":"11197_CR139","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-4-431-56847-6_2","volume":"1103","author":"S Wakao","year":"2018","unstructured":"Wakao, S., Kushida, Y., & Dezawa, M. (2018). Basic characteristics of Muse cells. Advances In Experimental Medicine And Biology, 1103, 13\u201341. https:\/\/doi.org\/10.1007\/978-4-431-56847-6_2","journal-title":"Advances In Experimental Medicine And Biology"},{"key":"11197_CR140","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-4-431-56847-6_17","volume":"1103","author":"M Dezawa","year":"2018","unstructured":"Dezawa, M. (2018). Clinical trials of Muse cells. Advances In Experimental Medicine And Biology, 1103, 305\u2013307. https:\/\/doi.org\/10.1007\/978-4-431-56847-6_17","journal-title":"Advances In Experimental Medicine And Biology"},{"key":"11197_CR141","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-4-431-56847-6_3","volume":"1103","author":"Y Kushida","year":"2018","unstructured":"Kushida, Y., Wakao, S., & Dezawa, M. (2018). Muse cells are endogenous reparative stem cells. Advances In Experimental Medicine And Biology, 1103, 43\u201368. https:\/\/doi.org\/10.1007\/978-4-431-56847-6_3","journal-title":"Advances In Experimental Medicine And Biology"},{"key":"11197_CR142","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-4-431-56847-6_6","volume":"1103","author":"MJ Perone","year":"2018","unstructured":"Perone, M. J., Gimeno, M. L., & Fuertes, F. (2018). Immunomodulatory properties and potential therapeutic benefits of muse cells administration in diabetes. Advances In Experimental Medicine And Biology, 1103, 115\u2013129. https:\/\/doi.org\/10.1007\/978-4-431-56847-6_6","journal-title":"Advances In Experimental Medicine And Biology"},{"issue":"13","key":"11197_CR143","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/cells12131676","volume":"12","author":"RF Alanazi","year":"2023","unstructured":"Alanazi, R. F., Alhwity, B. S., Almahlawi, R. M., et al. (2023). Multilineage differentiating stress enduring (MUSE) cells: A new era of stem cell-based therapy. Cells, 12(13), 1676. https:\/\/doi.org\/10.3390\/cells12131676","journal-title":"Cells"},{"key":"11197_CR144","doi-asserted-by":"publisher","first-page":"124024","DOI":"10.1016\/j.lfs.2025.124024","volume":"382","author":"A Rajabi","year":"2025","unstructured":"Rajabi, A., Akbarzadeh, S., Tayefeh-Gholami, S., & Bonyadi, M. (2025). The promising role of muse cells in regenerative medicine: Mechanisms, applications, and future directions. Life Sciences, 382, 124024. https:\/\/doi.org\/10.1016\/j.lfs.2025.124024","journal-title":"Life Sciences"},{"key":"11197_CR145","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/5584_2024_824","volume":"1474","author":"Z Baran","year":"2025","unstructured":"Baran, Z., \u00c7etinkaya, M., & Baran, Y. (2025). Mesenchymal stem cells in cancer therapy. Advances In Experimental Medicine And Biology, 1474, 149\u2013177. https:\/\/doi.org\/10.1007\/5584_2024_824","journal-title":"Advances In Experimental Medicine And Biology"},{"issue":"1","key":"11197_CR146","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41419-025-07443-0","volume":"16","author":"Y Shi","year":"2025","unstructured":"Shi, Y., Zhang, J., Li, Y., et al. (2025). Engineered mesenchymal stem\/stromal cells against cancer. Cell Death And Disease, 16(1), 113. https:\/\/doi.org\/10.1038\/s41419-025-07443-0","journal-title":"Cell Death And Disease"},{"key":"11197_CR147","doi-asserted-by":"publisher","first-page":"793","DOI":"10.18632\/oncotarget.28672","volume":"15","author":"T Minev","year":"2024","unstructured":"Minev, T., Balbuena, S., Gill, J. M., Marincola, F. M., Kesari, S., & Lin, F. (2024). Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists. Oncotarget, 15, 793\u2013805. https:\/\/doi.org\/10.18632\/oncotarget.28672","journal-title":"Oncotarget"},{"issue":"3","key":"11197_CR148","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/0115680266299112240514103048","volume":"25","author":"S Taeb","year":"2025","unstructured":"Taeb, S., Rostamzadeh, D., Amini, S. M., et al. (2025). Revolutionizing cancer treatment: harnessing the power of mesenchymal stem cells for precise targeted therapy in the tumor microenvironment. Current Topics In Medicinal Chemistry, 25(3), 243\u2013262. https:\/\/doi.org\/10.2174\/0115680266299112240514103048","journal-title":"Current Topics In Medicinal Chemistry"},{"key":"11197_CR149","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pcad.2025.08.008","volume":"92","author":"R Bolli","year":"2025","unstructured":"Bolli, R., Hare, J. M., Perin, E. C., Quyyumi, A., Butler, J., & Kalra, D. K. (2025). Cell therapy for heart failure -recent progress and future directions. Progress In Cardiovascular Diseases, 92, 66\u201379. https:\/\/doi.org\/10.1016\/j.pcad.2025.08.008","journal-title":"Progress In Cardiovascular Diseases"},{"key":"11197_CR150","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/17460751.2026","volume":"21","author":"A Madrazo-Ibarra","year":"2026","unstructured":"Madrazo-Ibarra, A., Seelan, A., Carroll, K. M., & Vad, V. B. (2026). Multilineage-differentiating stress-enduring (Muse) cells in ischemic heart disease. A systematic review of preclinical and clinical studies. Regenerative Medicine, 21, 281\u2013290. https:\/\/doi.org\/10.1080\/17460751.2026","journal-title":"Regenerative Medicine"},{"issue":"1","key":"11197_CR151","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13098-025-01619-6","volume":"17","author":"M Kashbour","year":"2025","unstructured":"Kashbour, M., Abdelmalik, A., Yassin, M. N. A., et al. (2025). Mesenchymal stem cell-based therapy for type 1 & 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome, 17(1), 189. https:\/\/doi.org\/10.1186\/s13098-025-01619-6","journal-title":"Diabetology & Metabolic Syndrome"},{"issue":"4","key":"11197_CR152","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41419-024-06659-w","volume":"15","author":"YR Jiao","year":"2024","unstructured":"Jiao, Y. R., Chen, K. X., Tang, X., et al. (2024). Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications. Cell Death And Disease, 15(4), 271. https:\/\/doi.org\/10.1038\/s41419-024-06659-w","journal-title":"Cell Death And Disease"},{"issue":"1","key":"11197_CR153","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s13287-024-03974-z","volume":"15","author":"A Zeinhom","year":"2024","unstructured":"Zeinhom, A., Fadallah, S. A., & Mahmoud, M. (2024). Human mesenchymal stem\/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives. Stem Cell Research & Therapy, 15(1), 384. https:\/\/doi.org\/10.1186\/s13287-024-03974-z","journal-title":"Stem Cell Research & Therapy"},{"issue":"4","key":"11197_CR154","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/s12015-026-11078-9","volume":"22","author":"D Bhartiya","year":"2026","unstructured":"Bhartiya, D. (2026). Relationship between VSELs, MUSE Cells and MSCs in health and disease. Stem Cell Rev Rep, 22(4), 2050\u20132060. https:\/\/doi.org\/10.1007\/s12015-026-11078-9","journal-title":"Stem Cell Rev Rep"},{"issue":"7","key":"11197_CR155","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s12015-023-10601-6","volume":"19","author":"A Kaushik","year":"2023","unstructured":"Kaushik, A., Metkari, S. M., Ali, S., & Bhartiya, D. (2023). Preventing\/reversing adverse effects of endocrine disruption on mouse testes by normalizing tissue resident VSELs. Stem Cell Rev Rep, 19(7), 2525\u20132540. https:\/\/doi.org\/10.1007\/s12015-023-10601-6","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"11197_CR156","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12015-023-10632-z","volume":"20","author":"P Singh","year":"2024","unstructured":"Singh, P., Metkari, S. M., Tripathi, A., & Bhartiya, D. (2024). Reversing uteropathies including cancer-like changes in mice by transplanting mesenchymal stromal cells or XAR treatment. Stem Cell Rev Rep, 20(1), 258\u2013282. https:\/\/doi.org\/10.1007\/s12015-023-10632-z","journal-title":"Stem Cell Rev Rep"},{"issue":"6","key":"11197_CR157","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12015-016-9685-1","volume":"12","author":"S Anand","year":"2016","unstructured":"Anand, S., Bhartiya, D., Sriraman, K., & Mallick, A. (2016). Underlying mechanisms that restore spermatogenesis on transplanting healthy niche cells in busulphan treated mouse testis. Stem Cell Rev Rep, 12(6), 682\u2013697. https:\/\/doi.org\/10.1007\/s12015-016-9685-1","journal-title":"Stem Cell Rev Rep"},{"issue":"6","key":"11197_CR158","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10059-010-0081-4","volume":"29","author":"DM Shin","year":"2010","unstructured":"Shin, D. M., Liu, R., Klich, I., Ratajczak, J., Kucia, M., & Ratajczak, M. Z. (2010). Molecular characterization of isolated from murine adult tissues very small embryonic\/epiblast like stem cells (VSELs). Molecules And Cells, 29(6), 533\u2013538. https:\/\/doi.org\/10.1007\/s10059-010-0081-4","journal-title":"Molecules And Cells"},{"issue":"7","key":"11197_CR159","doi-asserted-by":"publisher","first-page":"692","DOI":"10.18632\/aging.100354","volume":"3","author":"MZ Ratajczak","year":"2011","unstructured":"Ratajczak, M. Z., Kucia, M., Liu, R., et al. (2011). RasGrf1: genomic imprinting, VSELs, and aging. Aging (Albany NY), 3(7), 692\u2013697. https:\/\/doi.org\/10.18632\/aging.100354","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"11197_CR160","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1161\/CIRCRESAHA.118.314287","volume":"124","author":"MZ Ratajczak","year":"2019","unstructured":"Ratajczak, M. Z., Ratajczak, J., & Kucia, M. (2019). Very small embryonic-like stem cells (VSELs): An update and future directions. Circ Res, 124(2), 208\u2013210. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.314287","journal-title":"Circ Res"},{"issue":"12","key":"11197_CR161","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1038\/s12276-024-01359-z","volume":"56","author":"SM Lee","year":"2024","unstructured":"Lee, S. M., & Surani, M. A. (2024). Epigenetic reprogramming in mouse and human primordial germ cells. Experimental & Molecular Medicine, 56(12), 2578\u20132587. https:\/\/doi.org\/10.1038\/s12276-024-01359-z","journal-title":"Experimental & Molecular Medicine"},{"issue":"9","key":"11197_CR162","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrg2849","volume":"11","author":"K Baumann","year":"2010","unstructured":"Baumann, K. (2010). Stem cells: Holding onto the memories. Nature Reviews Genetics, 11(9), 593. https:\/\/doi.org\/10.1038\/nrg2849","journal-title":"Nature Reviews Genetics"},{"issue":"1609","key":"11197_CR163","doi-asserted-by":"publisher","first-page":"20120292","DOI":"10.1098\/rstb.2012.0292","volume":"368","author":"A Watanabe","year":"2013","unstructured":"Watanabe, A., Yamada, Y., & Yamanaka, S. (2013). Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. Philosophical Transactions Of The Royal Society Of London. Series B, Biological Sciences, 368(1609), 20120292. https:\/\/doi.org\/10.1098\/rstb.2012.0292","journal-title":"Philosophical Transactions Of The Royal Society Of London. Series B, Biological Sciences"},{"issue":"7313","key":"11197_CR164","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim, K., Doi, A., Wen, B., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467(7313), 285\u2013290. https:\/\/doi.org\/10.1038\/nature09342","journal-title":"Nature"},{"issue":"8","key":"11197_CR165","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nbt.1667","volume":"28","author":"JM Polo","year":"2010","unstructured":"Polo, J. M., Liu, S., Figueroa, M. E., et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology, 28(8), 848\u2013855. https:\/\/doi.org\/10.1038\/nbt.1667","journal-title":"Nature Biotechnology"},{"issue":"5","key":"11197_CR166","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2011.04.019","volume":"145","author":"B Papp","year":"2011","unstructured":"Papp, B., & Plath, K. (2011). Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell, 145(5), 647\u2013658. https:\/\/doi.org\/10.1016\/j.cell.2011.04.019","journal-title":"Cell"},{"key":"11197_CR167","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41232-020-00117-8","volume":"40","author":"T Ishida","year":"2020","unstructured":"Ishida, T., Nakao, S., Ueyama, T., Harada, Y., & Kawamura, T. (2020). Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1. Inflamm Regen, 40, 8. https:\/\/doi.org\/10.1186\/s41232-020-00117-8","journal-title":"Inflamm Regen"},{"key":"11197_CR168","doi-asserted-by":"publisher","unstructured":"Spyrou, J., Gardner, D. K., & Harvey, A. J. (2019). Metabolism is a key regulator of induced pluripotent stem cell reprogramming. Stem Cells Int, 2019:7360121. Published 2019 May 5. https:\/\/doi.org\/10.1155\/2019\/7360121","DOI":"10.1155\/2019\/7360121"},{"key":"11197_CR169","doi-asserted-by":"publisher","unstructured":"Anand, S., Patel, H., & Bhartiya, D. (2015). Chemoablated mouse seminiferous tubular cells enriched for very small embryonic-like stem cells undergo spontaneous spermatogenesis in vitro. Reprod Biol Endocrinol, 13:33. Published 2015 Apr 18. https:\/\/doi.org\/10.1186\/s12958-015-0031-2","DOI":"10.1186\/s12958-015-0031-2"},{"issue":"5","key":"11197_CR170","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12015-018-9832-y","volume":"14","author":"I Virant-Klun","year":"2018","unstructured":"Virant-Klun, I. (2018). Functional testing of primitive oocyte-like cells developed in ovarian surface epithelium cell culture from small VSEL-like stem cells: Can they be fertilized one day? Stem Cell Rev Rep, 14(5), 715\u2013721. https:\/\/doi.org\/10.1007\/s12015-018-9832-y","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"11197_CR171","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13048-018-0454-4","volume":"11","author":"K James","year":"2018","unstructured":"James, K., Bhartiya, D., Ganguly, R., et al. (2018). Gonadotropin and steroid hormones regulate pluripotent very small embryonic-like stem cells in adult mouse uterine endometrium. J Ovarian Res, 11(1), 83. https:\/\/doi.org\/10.1186\/s13048-018-0454-4","journal-title":"J Ovarian Res"},{"key":"11197_CR172","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13287-022-02703-8","volume":"13","author":"P Singh","year":"2022","unstructured":"Singh, P., Metkari, S., & Bhartiya, D. (2022). Additional evidence to support OCT-4 positive VSELs and EnSCs as the elusive tissue-resident stem\/progenitor cells in adult mice uterus. Stem Cell Research & Therapy, 13, 60. https:\/\/doi.org\/10.1186\/s13287-022-02703-8","journal-title":"Stem Cell Research & Therapy"},{"issue":"9","key":"11197_CR173","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1038\/leu.2015.100","volume":"29","author":"A Shaikh","year":"2015","unstructured":"Shaikh, A., Nagvenkar, P., Pethe, P., Hinduja, I., & Bhartiya, D. (2015). Molecular and phenotypic characterization of CD133 and SSEA4 enriched very small embryonic-like stem cells in human cord blood. Leukemia, 29(9), 1909\u20131917. https:\/\/doi.org\/10.1038\/leu.2015.100","journal-title":"Leukemia"},{"issue":"8","key":"11197_CR174","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/leu.2010.121","volume":"24","author":"DM Shin","year":"2010","unstructured":"Shin, D. M., Liu, R., Klich, I., et al. (2010). Molecular signature of adult bone marrow-purified very small embryonic-like stem cells supports their developmental epiblast\/germ line origin. Leukemia, 24(8), 1450\u20131461. https:\/\/doi.org\/10.1038\/leu.2010.121","journal-title":"Leukemia"},{"issue":"8","key":"11197_CR175","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.celrep.2017.01.074","volume":"18","author":"J Heo","year":"2017","unstructured":"Heo, J., Lim, J., Lee, S., et al. (2017). Sirt1 regulates DNA methylation and differentiation potential of embryonic stem cells by antagonizing Dnmt3l. Cell Rep, 18(8), 1930\u20131945. https:\/\/doi.org\/10.1016\/j.celrep.2017.01.074","journal-title":"Cell Rep"},{"issue":"2","key":"11197_CR176","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12015-016-9714-0","volume":"13","author":"A Shaikh","year":"2017","unstructured":"Shaikh, A., Anand, S., Kapoor, S., Ganguly, R., & Bhartiya, D. (2017). Mouse bone marrow vsels exhibit differentiation into three embryonic germ lineages and germ & hematopoietic cells in culture. Stem Cell Rev Rep, 13(2), 202\u2013216. https:\/\/doi.org\/10.1007\/s12015-016-9714-0","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"11197_CR177","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12958-017-0308-8","volume":"15","author":"D Bhartiya","year":"2017","unstructured":"Bhartiya, D., Anand, S., Patel, H., & Parte, S. (2017). Making gametes from alternate sources of stem cells: past, present and future. Reproductive Biology And Endocrinology : Rb&E, 15(1), 89. https:\/\/doi.org\/10.1186\/s12958-017-0308-8","journal-title":"Reproductive Biology And Endocrinology : Rb&E"},{"issue":"6","key":"11197_CR178","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCRESAHA.118.313823","volume":"124","author":"D Bhartiya","year":"2019","unstructured":"Bhartiya, D. (2019). Clinical translation of stem cells for regenerative medicine. Circ Res, 124(6), 840\u2013842. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313823","journal-title":"Circ Res"},{"issue":"1","key":"11197_CR179","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12015-023-10632-z","volume":"20","author":"P Singh","year":"2024","unstructured":"Singh, P., Metkari, S. M., Tripathi, A., & Bhartiya, D. (2024). Reversing uteropathies including cancer-like changes in mice by transplanting mesenchymal stromal cells or XAR treatment. Stem Cell Rev Rep, 20(1), 258\u2013282. https:\/\/doi.org\/10.1007\/s12015-023-10632-z","journal-title":"Stem Cell Rev Rep"},{"issue":"7","key":"11197_CR180","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s12015-023-10601-6","volume":"19","author":"A Kaushik","year":"2023","unstructured":"Kaushik, A., Metkari, S. M., Ali, S., & Bhartiya, D. (2023). Preventing\/reversing adverse effects of endocrine disruption on mouse testes by normalizing tissue resident VSELs. Stem Cell Rev Rep, 19(7), 2525\u20132540. https:\/\/doi.org\/10.1007\/s12015-023-10601-6","journal-title":"Stem Cell Rev Rep"},{"key":"11197_CR181","doi-asserted-by":"publisher","unstructured":"Bhartiya, D., & Patel, H. (2015). Very small embryonic-like stem cells are involved in pancreatic regeneration and their dysfunction with age may lead to diabetes and cancer. Stem Cell Res Ther, 6(1):96. Published 2015 May 15. https:\/\/doi.org\/10.1186\/s13287-015-0084-3","DOI":"10.1186\/s13287-015-0084-3"},{"issue":"1","key":"11197_CR182","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cells14010034","volume":"14","author":"J Hahm","year":"2025","unstructured":"Hahm, J., Kumar, D., Andrade, J. A. F., Arany, E., & Hill, D. J. (2025). Bi-hormonal endocrine cell presence within the islets of Langerhans of the human pancreas throughout life. Cells, 14(1), 34. https:\/\/doi.org\/10.3390\/cells14010034","journal-title":"Cells"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11197-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:58:52Z","timestamp":1788764332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11197-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":182,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11197"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11197-3","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial details","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author works at TZAR Genomics Pvt Ltd, with an interest in VSELs biology.","order":5,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}